ro 31-8220 has been researched along with Animal Mammary Carcinoma in 1 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erin, N | 1 |
| Tavşan, E | 1 |
| Akdeniz, Ö | 1 |
| Isca, VMS | 1 |
| Rijo, P | 1 |
1 other study available for ro 31-8220 and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKCδ and PKCε activators.
Topics: Alkanes; Animals; Bryostatins; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL2; Chemokines; Cy | 2021 |